This cross-sectional study analyzed clinical and biochemical data from women with PCOS to identify and validate three distinct phenotypes (A, B, C) with different underlying hormonal and metabolic pathways.
Reproductive Sciences · 9 authors, 2 centres
This summary was generated by AI from a single paper. It has not been reviewed by a clinician and is not clinical advice. Verify against the source before acting on it.
This cross-sectional study analyzed clinical and biochemical data from women with PCOS to identify and validate three distinct phenotypes (A, B, C) with different underlying hormonal and metabolic pathways.
This cross-sectional study aimed to characterize and validate clinical phenotypes in women with PCOS. Using data from two independent cohorts (Kuwait and Rotterdam), the researchers identified three distinct phenotypes: Phenotype A (neuroendocrine dysfunction, high LH, excess ovarian androgens), Phenotype B (metabolic dysfunction, obesity, insulin resistance), and Phenotype C (adrenal hyperandrogenism, regular cycles). The classification was supported by cluster analyses from prior independent studies. The study links each phenotype to a primary biochemical pathway and putative genetics, such as DENND1A for A, Grb14 for B, and an unclear driver for C. The findings suggest that these phenotypes may guide more targeted research and personalized treatment strategies for PCOS.